Type
. [Silent neuropathy in patients with leprosy in the city of Fortaleza, Ceará State, Brazil]. Cadernos de saude publica [Internet]. 2011;27(4):659-65. Available from: http://www.scielosp.org/pdf/csp/v27n4/05.pdf
Type
. Distribution of the HLA class II frequency alleles in patients with leprosy from the mid-west of Brazil. International journal of immunogenetics. 2011;38(3):255-8.
Type
. Association between neuropathic pain and A-waves in leprosy patients with type 1 and 2 reactions. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. 2011;28(3):329-32.
Type
. [Molecular confirmation of an especially difficult to diagnose case of leprosy]. Enfermedades infecciosas y microbiologia clinica. 2012;30(5):276-7.
Type
. Elimination of leprosy & possibility of eradication - the Indian scenario. The Indian journal of medical research [Internet]. 2012;135:3-5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307180/?report=printable
Type
. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions. Pharmacotherapy. 2012;32(1):27-37.
Type
. Lepra. 1stst ed. Suriname Informatie. Veka Productions; 2011.
Type
. Towards the molecular epidemiology of Mycobacterium leprae: strategies, successes, and shortcomings. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2011;11(7):1505-13.
Type
. ML1419c peptide immunization induces Mycobacterium leprae-specific HLA-A*0201-restricted CTL in vivo with potential to kill live mycobacteria. Journal of immunology (Baltimore, Md. : 1950) [Internet]. 2011;187(3):1393-402. Available from: https://www.jimmunol.org/content/jimmunol/187/3/1393.full.pdf
Type
. Leprosy and HIV coinfection: a critical approach. Expert review of anti-infective therapy. 2011;9(6):701-10.